Cysteinyl leukotriene E4 activates human ILC2s and enhances the effect of prostaglandin D2 and epithelial cytokines
<strong>Background:</strong> Group 2 innate lymphoid cells (ILC2) are a potential innate source of type-2 cytokines in the pathogenesis of allergic conditions. Epithelial cytokines (IL-33, IL-25 and TSLP) and mast cell mediators (PGD2) are critical activators of ILC2s. Cysteinyl leukot...
Main Authors: | Salimi, M, Stoeger, L, Liu, W, Go, S, Pavord, I, Klenerman, P, Ogg, G, Xue, L |
---|---|
Format: | Journal article |
Published: |
Elsevier
2017
|
Similar Items
-
Cysteinyl Leukotriene Pathway and Cancer
by: Ming-Ju Tsai, et al.
Published: (2021-12-01) -
Leukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2.
by: Xue, L, et al.
Published: (2012) -
Cysteinyl-leukotrienes promote cutaneous Leishmaniasis control
by: Letícia Paula Trajano Noronha, et al.
Published: (2023-06-01) -
Prostaglandin D2 and leukotriene E4 synergize to stimulate diverse TH2 functions and TH2 cell/neutrophil crosstalk.
by: Xue, L, et al.
Published: (2015) -
Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics.
by: Macfarlane, A, et al.
Published: (2000)